Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Retained Earnings (2018 - 2025)

AVITA Medical (RCEL) has disclosed Retained Earnings for 4 consecutive years, with -$1.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings rose 29.5% year-over-year to -$1.4 million, compared with a TTM value of -$1.4 million through Dec 2025, up 29.5%, and an annual FY2025 reading of -$1.4 million, up 29.5% over the prior year.
  • Retained Earnings was -$1.4 million for Q4 2025 at AVITA Medical, up from -$396.8 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $7.8 million in Q1 2022 and bottomed at -$396.8 million in Q3 2025.
  • Average Retained Earnings over 4 years is -$156.8 million, with a median of -$127.4 million recorded in 2022.
  • The sharpest move saw Retained Earnings surged 99.45% in 2024, then crashed 24552.96% in 2025.
  • Year by year, Retained Earnings stood at $7.6 million in 2022, then tumbled by 4006.77% to -$298.0 million in 2023, then soared by 99.35% to -$1.9 million in 2024, then increased by 29.5% to -$1.4 million in 2025.
  • Business Quant data shows Retained Earnings for RCEL at -$1.4 million in Q4 2025, -$396.8 million in Q3 2025, and -$383.6 million in Q2 2025.